2m 2m 2m 2m 2m 2m 2m
Novartis Sp ADR (NVS)
NYSE
$152.65+$3.72 (+2.50%)
Price as of Jun 23, 2026 12:30 PM EDT- $284.2BMarket Cap
- 30.56%1-Year Change
- Drug Manufacturers - GeneralIndustry
Novartis Sp ADR (NVS)
$152.65+$3.72 (+2.50%)
NVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $148.93 | ||
Change | +$1.85 (+1.26%) | ||
Open | $146.94 | ||
High | $149.23 | ||
Low | $146.60 | ||
Previous Close | $147.08 | ||
Volume | 1,399,966 | ||
30-Day Average Volume | 1,810,614 | ||
1-Week Change | -1.74% | ||
1-Month Change | -2.03% | ||
1-Year Change | 30.56% | ||
3-Year Change | 64.27% | ||
5-Year Change | 92.79% | ||
Fundamentals | |||
Shares Outstanding | 1.9B | ||
Total Assets | $110.9B | ||
Market Cap | $284.2B | ||
Enterprise Value | $273.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 22.28% | ||
Trailing Annual Dividend Yield | 3.18% | ||
Ex-Dividend Date | 03/11/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield